Institutional investors hold a majority ownership of ABT through the 70.81% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Medical Specialties industry. Last, during the quarter ended December 2014, these large investors purchased a net $8.8 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
T. ROWE PRICE ASSOCIATES, INC. Bought 3.7 Million shares of Abbott Laboratories
MORGAN STANLEY SMITH BARNEY LLC Bought 3.4 Million shares of Abbott Laboratories
THE VANGUARD GROUP, INC. Bought 2.8 Million shares of Abbott Laboratories